Skip to main content

FDA Approvals

FDA Approvals, In the News, Select Drug Profiles

Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer

FDA Approvals, In the News, Select Drug Profiles

FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors

FDA Approvals, Select Drug Profiles

Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer

Lilly Ostrovsky

Drug Updates, FDA Approvals, Payers' Guide

ProAir RespiClick (Albuterol Sulfate): First Breath-Actuated Inhaler Approved for the Treatment or Prevention of Bronchospasm

Lisa A. Raedler, PhD, RPh

FDA Approvals, In the News, Select Drug Profiles

Venclexta FDA Approved for Patients with CLL

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Infliximab Biosimilar for Multiple Indications

FDA Approvals, In the News, Select Drug Profiles

FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Patients with Hemophilia B

20
21
22
23
24
25
26

Page 23 of 31
Results 221 - 230 of 305